Meisner Lara
SEC insider (Form 3/4/5 filer). CIK 0001883986. Chief Legal Officer at Bicara Therapeutics Inc. (BCAX). 10 reported Form 4/5 transactions since Sep 2024; latest on Feb 2, 2026. Located in BOSTON, MA.
Companies Meisner Lara has filed insider reports for
- Bicara Therapeutics Inc. (BCAX): Officer, Chief Legal Officer
Meisner Lara
CIK: 0001883986
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Bicara Therapeutics Inc.
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Feb 2, 2026BCAX
Bicara Therapeutics Inc.
AwardDirectStock Option (Right to Buy)
90K shares- - Sep 29, 2025BCAX
Bicara Therapeutics Inc.
SaleDirect33.8K shares at avg. $14.75$499K - Sep 29, 2025BCAX
Bicara Therapeutics Inc.
ExerciseDirect33.8K shares at avg. $9.24$312K - Sep 15, 2025BCAX
Bicara Therapeutics Inc.
ExerciseDirect15.8K shares at avg. $5.45$86K - Sep 15, 2025BCAX
Bicara Therapeutics Inc.
SaleDirect15.8K shares at avg. $11.49$182K - Jun 16, 2025BCAX
Bicara Therapeutics Inc.
ExerciseDirect15.8K shares at avg. $5.45$86K - Jun 16, 2025BCAX
Bicara Therapeutics Inc.
SaleDirect15.8K shares at avg. $10.43$165K - Mar 14, 2025BCAX
Bicara Therapeutics Inc.
SaleDirect30.6K shares at avg. $13.24$406K - Mar 14, 2025BCAX
Bicara Therapeutics Inc.
ExerciseDirect79.1K shares at avg. $5.45$431K - Mar 14, 2025BCAX
Bicara Therapeutics Inc.
SaleDirect48.5K shares at avg. $12.69$616K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 2, 2026 | BCAX Bicara Therapeutics Inc. | Award Stock Option (Right to Buy) | 90,000 | - | - | Direct |
| Sep 29, 2025 | BCAX Bicara Therapeutics Inc. | Sale | 33,807 | $14.75 | $498,653 | Direct |
| Sep 29, 2025 | BCAX Bicara Therapeutics Inc. | Exercise | 33,807 | $9.24 | $312,495 | Direct |
| Sep 15, 2025 | BCAX Bicara Therapeutics Inc. | Exercise | 15,829 | $5.45 | $86,268 | Direct |
| Sep 15, 2025 | BCAX Bicara Therapeutics Inc. | Sale | 15,829 | $11.49 | $181,875 | Direct |
| Jun 16, 2025 | BCAX Bicara Therapeutics Inc. | Exercise | 15,829 | $5.45 | $86,268 | Direct |
| Jun 16, 2025 | BCAX Bicara Therapeutics Inc. | Sale | 15,829 | $10.43 | $165,096 | Direct |
| Mar 14, 2025 | BCAX Bicara Therapeutics Inc. | Sale | 30,620 | $13.24 | $405,513 | Direct |
| Mar 14, 2025 | BCAX Bicara Therapeutics Inc. | Exercise | 79,146 | $5.45 | $431,346 | Direct |
| Mar 14, 2025 | BCAX Bicara Therapeutics Inc. | Sale | 48,526 | $12.69 | $615,698 | Direct |
1-10 of 10 transactions